Study of the Effectiveness of Rituximab in Adults With Chronic and Severe Immune Thrombocytopenic Purpura and Candidate for a Splenectomy
Clinical trial NCT00225875 · TERMINATED
Trial details
- NCT number
- NCT00225875
- Sponsor
- Assistance Publique - Hôpitaux de Paris
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2003-09-01
- Enrollment
- 65
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.